Kenneth Warrington
Keine laufenden Positionen mehr
Karriereverlauf von Kenneth Warrington
Ehemalige bekannte Positionen von Kenneth Warrington
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Lacerta Therapeutics, Inc.
 Lacerta Therapeutics, Inc. BiotechnologyHealth Technology Lacerta Therapeutics, Inc. operates as a a clinical stage gene therapy company. The firm engages in development, production, and application of AAV vectors. The company was founded by Nicholas Muzyczka, Barry Byrne, Arun Srivastava, Coy Heldermon, Sergei Zolothukin, Kenneth Warrington, Ronald Mandel, Toadd E. Golde and Edgardo Rodriguez in 2017 and is headquartered in Alachua, FL. | Direktor/Vorstandsmitglied | 01.01.2017 | - |
| Technik-/Wissenschafts-/F&E-Leiter | 01.03.2022 | - | |
| Gründer | 01.01.2017 | - |
Ausbildung von Kenneth Warrington
| University of Florida | Doctorate Degree |
Statistik
International
| Vereinigte Staaten | 3 |
Operativ
| Director/Board Member | 1 |
| Chief Tech/Sci/R&D Officer | 1 |
| Founder | 1 |
Sektoral
| Health Technology | 2 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
Lacerta Therapeutics, Inc.
Lacerta Therapeutics, Inc. BiotechnologyHealth Technology Lacerta Therapeutics, Inc. operates as a a clinical stage gene therapy company. The firm engages in development, production, and application of AAV vectors. The company was founded by Nicholas Muzyczka, Barry Byrne, Arun Srivastava, Coy Heldermon, Sergei Zolothukin, Kenneth Warrington, Ronald Mandel, Toadd E. Golde and Edgardo Rodriguez in 2017 and is headquartered in Alachua, FL. | Health Technology |
- Börse
- Insiders
- Kenneth Warrington
- Erfahrung
